James M Stone

Cited by

	All	Since 2016
Citations	8044	4826
h-index	40	35
i10-index	78	66

1300

650

325

975

199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202129 36 32 21 27 17 25 16 29 33 67 106 143 206 248 432 427 509 614 646 714 818 948 1262 431

Public access

View all

48 articles

5 articles

available

not available

Based on funding mandates

Co-authors

Gareth J BarkerProfessor of Magnetic Resonance Physics, King's College LondonVerified email at kcl.ac.uk
David J LythgoeLondon OR ManchesterVerified email at kcl.ac.uk
Shitij KapurUniversity of MelbourneVerified email at unimelb.edu.au
Fusar-Poli PaoloPrimary: King's College London, UK; Secondary: University of Pavia, ItalyVerified email at kcl.ac.uk
Robin M Murrayinstitute of psychiatry, psychology, and neuroscienceVerified email at kcl.ac.uk
S BhattacharyyaKing's College London, Institute of PsychiatryVerified email at kcl.ac.uk
Rodrigo Affonseca Bressan, MD, PhDProfessor Adjunto Livre Docente, Universidade Federal de São PauloVerified email at psiquiatria.epm.br
Gemma ModinosInstitute of Psychiatry, Psychology & Neuroscience, King's College LondonVerified email at kcl.ac.uk
Mitul MehtaProfessor of Neuroimaging & Psychopharmacology, Institute of Psychiatry, Psychology & NeuroscienceVerified email at kcl.ac.uk
Matthew BroomeProfessor of Psychiatry and Youth Mental Health, University of BirminghamVerified email at bham.ac.uk
Erik ArstadUniversity College LondonVerified email at ucl.ac.uk
Allan YoungKing's College LondonVerified email at kcl.ac.uk
Stefan P BruggerCUBRIC, Cardiff University; Centre for Academic Mental Health, University of BristolVerified email at cardiff.ac.uk
Dr Stefania TogninInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London UKVerified email at kcl.ac.uk
Robert A McCutcheonInstitute of Psychiatry, Psychology and NeuroscienceVerified email at kcl.ac.uk
Stefan BorgwardtUniversity of LübeckVerified email at unibas.ch
Sameer JauharSenior Clinical Lecturer, Institute of Psychiatry, King's College, LondonVerified email at kcl.ac.uk
Fiona PepperInstitute of Psychiatry, Psychology and Neuroscience, KCLVerified email at kcl.ac.uk
Valmaggia LuciaReader in Clinical Psychology and Digital Mental Health, King's College London, Institute ofVerified email at kcl.ac.uk
Kate MerrittUniversity College LondonVerified email at ucl.ac.uk

James M Stone

Brighton and Sussex Medical School; University of Sussex; University of Brighton

Verified email at bsms.ac.uk

psychiatry ketamine glutamate psilocybin THC


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ... Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012	730	2012
Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ... Neuropsychopharmacology 35 (3), 764-774, 2010	612	2010
Glutamate and dopamine in schizophrenia: An update for the 21^st century O Howes, R McCutcheon, J Stone Journal of psychopharmacology 29 (2), 97-115, 2015	560	2015
Glutamate and dopamine dysregulation in schizophrenia—a synthesis and selective review JM Stone, PD Morrison, LS Pilowsky Journal of psychopharmacology 21 (4), 440-452, 2007	459	2007
Complex I inhibitors induce dose‐dependent apoptosis in PC12 cells: relevance to Parkinson's disease A Hartley, JM Stone, C Heron, JM Cooper, AHV Schapira Journal of neurochemistry 63 (5), 1987-1990, 1994	441	1994
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment A Englund, PD Morrison, J Nottage, D Hague, F Kane, S Bonaccorso, ... Journal of psychopharmacology 27 (1), 19-27, 2013	350	2013
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ... Molecular psychiatry 11 (2), 118-119, 2006	297	2006
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology JM Stone, C Dietrich, R Edden, MA Mehta, S De Simoni, LJ Reed, ... Molecular psychiatry 17 (7), 664-665, 2012	244	2012
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study A Mechelli, A Riecher-Rössler, EM Meisenzahl, S Tognin, SJ Wood, ... Archives of general psychiatry 68 (5), 489-495, 2011	243	2011
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ... Biological psychiatry 66 (6), 533-539, 2009	240	2009
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ... Biological psychiatry 75 (5), e11-e13, 2014	236	2014
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis RL Carhart-Harris, R Leech, D Erritzoe, TM Williams, JM Stone, J Evans, ... Schizophrenia bulletin 39 (6), 1343-1351, 2013	165	2013
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia A Egerton, S Brugger, M Raffin, GJ Barker, DJ Lythgoe, PK McGuire, ... Neuropsychopharmacology 37 (11), 2515-2521, 2012	164	2012
Functional neuroimaging in schizophrenia: diagnosis and drug discovery P McGuire, OD Howes, J Stone, P Fusar-Poli Trends in pharmacological sciences 29 (2), 91-98, 2008	156	2008
Proton magnetic resonance spectroscopy and illness stage in schizophrenia—a systematic review and meta-analysis S Brugger, JM Davis, S Leucht, JM Stone Biological psychiatry 69 (5), 495-503, 2011	155	2011
Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ... Schizophrenia bulletin 42 (3), 744-752, 2016	137	2016
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis JM Stone, OD Howes, A Egerton, J Kambeitz, P Allen, DJ Lythgoe, ... Biological psychiatry 68 (7), 599-602, 2010	128	2010
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis P Fusar-Poli, JM Stone, MR Broome, I Valli, A Mechelli, MA McLean, ... Archives of general psychiatry 68 (9), 881-890, 2011	127	2011
Drug models of schizophrenia H Steeds, RL Carhart-Harris, JM Stone Therapeutic advances in psychopharmacology 5 (1), 43-58, 2015	113	2015
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123 I] CNS-1261 SPET study JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ... Psychopharmacology 197 (3), 401-408, 2008	107	2008

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors